Being hit by counterfeit medicines, patent violations, security issues, and improper handling of medicines, the U.S. Pharmacopeial Convention (USP) is beginning a campaign to develop supply chain visibility best practices for that industry. The main goal for the USP is to ensure that medicines can be traced back to their original manufacturer and ensure they arrive at their intended destination without tampering or damage, all while verifying that they are not adulterated or counte...